Alphabet Inc Class A vs Smith & Nephew plc — how do they compare? Alphabet Inc Class A trades at $351.66 (market cap $4.24T), while Smith & Nephew plc trades at $27.24 (market cap $11.10B). The key difference: Alphabet Inc Class A is far larger — about 382× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold Alphabet Inc Class A for 85 Days and Smith & Nephew plc for 121 Days on average.
| GOOGL | SNN | |
|---|---|---|
Market Cap | $4.24T | $11.10B |
Volume | 23,392,850 | 1,051,703 |
Sector | Media | Health |
52-Week High | $402.62 | $37.17 |
52-Week Low | $236.59 | $26.42 |
Typical Hold Time | 85 Days | 121 Days |
Enterprise Value | $4.13T | $14.13B |
Dividend Yield | 0.25% | 2.95% |
Signals from Pluang's Aura AI — not financial advice
Alphabet (GOOGL) trades at $348.29, down 0.63% on the day, with strong technical support at $346 and resistance at $352. The company demonstrates robust fundamentals with 2025 revenue of $402.84B and net income of $132.17B, achieving a 32.8% profit margin. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $9.11 surpassing the $2.87 estimate. Analyst consensus remains overwhelmingly bullish with 87% buy ratings and a $431.83 price target, representing 24% upside potential.
Alphabet presents a compelling investment case driven by AI leadership, strong cash flow generation, and consistent earnings outperformance. Key risks include regulatory scrutiny, competitive pressures in search and cloud, and market volatility. The stock's current valuation at 17.48x P/E appears reasonable given growth prospects, while technical indicators suggest near-term consolidation within a defined trading range.
SNN trades at $26.96, up 0.26% on the day, but near its 52-week low amid a bearish technical signal. Recent earnings have mostly beaten expectations, with Q2 2026 EPS of $0.946 exceeding the $0.939 estimate. Revenue grew to $6.16B in 2025, and net income margin improved to 10.08%. The company continues to launch new medical products, such as the EVOS PELVIC System, to drive growth.
The outlook is mixed; strong fundamentals and product innovation support long-term value, but near-term price pressure and analyst caution pose risks. Investors should weigh robust profitability against competitive threats and recent management changes.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Read more on GOOGL →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →